Arthur A Levin is of Stoke Therapeutics, Inc.. Currently has a direct ownership of 0 shares of STOK, which is worth approximately $0. The most recent transaction as insider was on Mar 01, 2021, when has been sold 12,500 shares (Common Stock) at a price of $60.84 per share, resulting in proceeds of $760,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

ARTHUR A LEVIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2021
SELL
Open market or private sale
$760,500 $60.84 p/Share
12,500 Reduced 100.0%
0 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
$5,875 $0.47 p/Share
12,500 Added 50.0%
12,500 Common Stock

Also insider at

RNA
Avidity Biosciences, Inc. Healthcare
AAL

Arthur A Levin

San Diego, CA

Track Institutional and Insider Activities on STOK

Follow Stoke Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STOK shares.

Notify only if

Insider Trading

Get notified when an Stoke Therapeutics, Inc. insider buys or sells STOK shares.

Notify only if

News

Receive news related to Stoke Therapeutics, Inc.

Track Activities on STOK